Document is current
Any future updates will be listed below
-
Authors
Guha, Chandana https://orcid.org/0000-0002-0767-4185
Khalid, Rabia https://orcid.org/0000-0002-2653-5834
van Zwieten, Anita https://orcid.org/0000-0003-4564-5825
Francis, Anna https://orcid.org/0000-0001-5106-3712
Hawley, Carmel M. https://orcid.org/0000-0002-1392-5649
Jauré, Allison
Teixeira-Pinto, Armando https://orcid.org/0000-0002-9389-2516
Mallard, Alistair R. https://orcid.org/0000-0002-7961-1458
Bernier-Jean, Amelie https://orcid.org/0000-0002-2357-6876
Johnson, David W. https://orcid.org/0000-0001-5491-3460
Hahn, Deirdre https://orcid.org/0000-0002-2105-146X
Reidlinger, Donna https://orcid.org/0000-0002-3365-9923
Pascoe, Elaine M. https://orcid.org/0000-0003-1653-5803
Ryan, Elizabeth G. https://orcid.org/0000-0001-9367-4204
Mackie, Fiona https://orcid.org/0000-0001-5042-5988
McCarthy, Hugh J. https://orcid.org/0000-0001-7357-4310
Craig, Jonathan C. https://orcid.org/0000-0002-2548-4035
Varghese, Julie
Kiriwandeniya, Charani https://orcid.org/0000-0002-9470-2948
Howard, Kirsten https://orcid.org/0000-0002-0918-7540
Larkins, Nicholas G. https://orcid.org/0000-0002-6914-4884
Macauley, Luke https://orcid.org/0000-0003-1870-0649
Walker, Amanda https://orcid.org/0000-0002-4567-5971
Howell, Martin https://orcid.org/0000-0001-9740-712X
Irving, Michelle https://orcid.org/0000-0001-7526-6258
Caldwell, Patrina H. Y. https://orcid.org/0000-0003-1124-6578
Woodleigh, Reginald https://orcid.org/0000-0002-6435-7880
Jesudason, Shilpanjali https://orcid.org/0000-0001-9695-0761
Carter, Simon A. https://orcid.org/0000-0001-7884-7015
Kennedy, Sean E. https://orcid.org/0000-0002-8801-2254
Alexander, Stephen I. https://orcid.org/0000-0002-3609-4446
McTaggart, Steven https://orcid.org/0000-0002-0887-8323
Wong, Germaine https://orcid.org/0000-0001-8422-7269
- License Information
-
More Information
Article History
Received: 19 May 2022
Revised: 16 September 2022
Accepted: 23 September 2022
First Online: 20 October 2022
Declarations
:
: Ethics approval for NAVKIDS2 study was obtained from Sydney Children’s Hospital Network Human Research Ethics Committee (approval HREC/18/SCHN/325) and the University of Queensland Human Research Ethics Committee (clearance number 2019002528).
: Consent has been obtained from parents of all the participants and assent from participants aged 16 or of sufficient maturity in the NAVKIDS2 trial.
: Not applicable.
: RW is the Program Director of CanCare, a patient navigation program for cancer patients run by the Prostate and Breast Cancer Foundation, Australia. DJ has received consultancy fees, research grants, speaker’s honoraria, and travel sponsorships from Baxter Healthcare and Fresenius Medical Care; consultancy fees from Astra Zeneca, Bayer, and AWAK; speaker’s honoraria from ONO and BI & Lilly; and travel sponsorships from Ono and Amgen. He is a current recipient of an Australian National Health and Medical Research Council Leadership Investigator Grant. CH institution received Baxter (provision of investigational agent for a study). Other authors declare that they have no competing interests.
